The results showed that the expression of HAS-1 in MDS-MNC was higher than normal controls (p = 0.027), and lower-risk MDS-MNC also exhibited significant higher HAS-1 expression than normal controls (p = 0.011; Fig. 2c). The gene discussed is HAS1; the disease is myelodysplastic syndrome.